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Equivalence Testing in Agriculture Experiments 
Brian J. Fergen 
Pfizer Animal Health Group 
Abstract 
Equivalence testing is a relatively new area of research in statistics. It's development has 
been motivated in large part by the need for statistical methods for determining if generic 
drugs are bioequivalent to their name brand counterparts. The application of equivalence 
testing methods to data resulting from experiments and surveys unrelated to drug 
development, and in particular agriculture-related experiments, is infrequent and possibly 
non-existent. These methods provide useful alternatives to the analysis methods 
currently being used. In this paper, an overview of the philosophy of equivalence testing 
and a review of equivalence testing methods are presented. Additionally, experimental 
situations for which equivalence testing would be appropriate are discussed. Examples 
that illustrate the application ofthe philosphy of equivalence testing to experimental 
designs commonly used in agriculture research are also presented. 
Keywords: Equivalence Testing, Completely Randomized Design, Split-plot Design 
1 Introduction 
The analysis of data resulting from experimental designs commonly used in agriculture typically 
proceed according to the hypothesis testing structure corresponding to the Analysis of Variance 
(ANOVA), General Linear Mixed Models (GLMM) or Generalized Linear Models (GLM) 
analysis methods. In this paper, the application of any ofthese methods and their related 
hypothesis testing structure is referred to as a traditional analysis. In many situations, a 
traditional analysis is appropriate, and the results from the hypothesis tests provide information 
that is relevant to the objectives of the study. However, for this to be the case, the objectives of 
the study must be in agreement with the hypothesis testing structure related to the analysis 
method used. If the objectives ofthe study are not in agreement with the hypothesis tests 
conducted, the conclusions are likely incorrect. 
A common situation where the hypothesis testing structure is not appropriate is when the 
objectives involve demonstrating the comparability or equivalence of parameters. In this 
situation neither the ANOV A, GLMM or GLM hypothesis testing approaches are appropriate. It 
is this situation that is commonly referred to as equivalence testing. 
The topics discussed in this paper: what is equivalence testing; why use equivalence testing; 
current equivalence testing methods, and examples of equivalence testing; provide a brief history 
of equivalence testing, the motivation for using equivalence testing, and a broad overview of 
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equivalence testing methods. In addition, the examples provide a bridge between the philosophy 
of equivalence testing and its application to agriculture experiments. 
2 What is Equivalence Testing 
As an introduction to equivalence testing, consider the application of equivalence testing that has 
motivated most of the research in equivalence testing - bioequivalence. Bioequivalence is the 
assessment of the comparability (the words equivalence and comparability are used 
interchangeably throughout this paper) of the bioavailabilty of two formulations of a drug, such 
as Name Brand and Generic formulations. The interest in bioequivalence reflects the need for 
appropriate statistical methods to assess the equivalence of parameters indicative of the 
therapeutic effect of a drug. While the literature for equivalence testing dates back at least as far 
as Bondy (1969), Westlake (1972) and Metzler (1974) introduce the concept of equivalence 
testing in the setting ofbioavailablilty - bioequivalence. Indeed, the majority of publications 
dealing with equivalence testing are motivated by and relate to bioequivalence. Thus it is 
appropriate to introduce equivalence testing by considering bioequivalence. 
Let 110 = average response for a Generic drug, and IlNB = average response for the Name Brand 
drug, for a response considered indicative of the therapeutic effect of the drug. To conclude the 
drugs are bioequivalent, it must be demonstrated that 110 and IlNB are comparable. The Food and 
Drug Administration has determined that two formulations can be declared bioequivalent if it 
can be demonstrated that the ratio of Generic to Name Brand average responses is greater than 
0.8 and less than 1.25. This requirement can be expressed via null and alternative hypotheses as 
110 IlG IlG Ho: 0.8 ~ -- or - ~ 1.25 vs HA : 0.8 < -- < 1.25. For the analysis of data from 
IlNB IlNB IlNB 
a bioequivalence trial, it is assumed that the null hypothesis is true. The objective of the study is 
then to demonstrate the alternative hypothesis is true, i.e. the two formulations are bioequivalent. 
This is the typical manner in which hypothesis testing is conducted, assume the null hypothesis 
is true, and demonstrate the research objective by demonstrating the alternative hypothesis is 
true. To model the physiological process involved in the assessment ofbioavailabilty, the 
analysis is conducted on the log transformed data. Under the assumption of equal formulation 
variances, this is equivalent to testing 
Ho: -/). ~ 0G - 0NB or 0G - 0NB ~ /). vs HA : -/). < 0G - 0NB < /)., where oj=ln(llj), and 
/). = In(1.25). The key to a bioequivalence test, and what differentiates it from hypothesis tests 
conducted in traditional analyses, is that the alternative hypothesis indicates the comparability 
of 110 and IlNB' 
It is also reasonable to expect that the concept of equivalence is appropriate in some agriculture 
research. As an example, consider a Canada Thistle Study to determine if two eradication 
methods result in comparable canada thistle counts two years after application. The methods 
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compared are the Standard Method (SM) - the application of a common herbicide in conjunction 
with tilling, and a New Method (NM) - mowing in conjunction with tilling. The study design 
has a One-Way Treatment Structure, where the treatments are the New and Standard Methods of 
eradication, with a Randomized Complete Block Design Structure, where the blocks are various 
locations in fields. The experimental unit is a plot of constant size and the response of interest is 
the number of thistles on a plot 2 years after the application of an eradication method. 
An appropriate model is Yij = fli + bj + eij' i = SM, NM; j = 1, 2, ... , k, where fli = average count 
for eradication method i, bj = random effect due to locationj (E(b) = 0, V(b) = Ob2), and 
eij = random error associated with treatment i in blockj (E(eij) = 0, V(ei) = o?). Typically, it is 
assumed that the random components of the model are independent (all bj and eij are 
independent). 
The objective of the study is to determine if the eradication methods result in comparable thistle 
counts. It might be appropriate to assess this objective by 
• * * * 
testing Ho: AL ~ flm1- flSM or flm1- flSM ~ Au vs HA : AL < flNM - flSM < Au· If the assessment 
of the comparability of the variability of the eradication methods is important, 
2 2 2 
+ 0NM 0NM + + 0NM + 
Ho: AL ~ -- or -- ~ Au vs HA : AL < -2- < Au could also be tested. It may also 
2 2 
0SM 0SM 0SM 
be reasonable to assess the objectives of the study by determining the comparability of both the 
means and variances of the eradication methods. Regardless of the hypothesis testes) used, it is 
appropriate to specifY the comparability of the parameters in terms of a lower and upper limit 
(AL and Au) and, through the hypothesis testing process, attempt to demonstrate that the 
alternative hypothesis is true and the eradication methods are comparable. 
It is important to note that the objective is not to demonstrate the superiority ofNM to SM, but 
the comparability of the methods. Interest in this objective may be related to cost ofNM vs SM, 
an ecological benefit associated with eliminating the use of the herbicide, and/or a variety of 
other reasons. Whatever the underlying reasons might be, establishing that the the eradication 
methods are comparable provides a basis from which the underlying reason can be put forth by 
the researcher as the justification for switching to the New Method. If the traditional approach 
had been used, failure to reject the null hypothesis does not demonstrate that the methods are 
comparable. 
At this point, equivalence testing is formally defined. Equivalence testing is the statistical 
assessment of the comparability of functions of parameters related to the distribution of random 
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variables, or of properties of the distribution of probabilities related to the comparability of 
random variables. This assessment requires a guideline (e.g., ~L and ~u) to be used in the 
determination of equivalence where the interval (~u ~u) is referred to as the equivalence 
interval. 
3 Why Use Equivalence Testing 
The primary reason to use equivalence testing is that it is correctly assessing the objectives of the 
experiment. This is reflected in the performance of the decision rules corresponding to the 
hypothesis tests for an equivalence analysis and a traditional analysis, as indicated in 
Schuirmann (1987). This performance is now illustrated for the Canada Thistle Study previously 
described. 
Recall the model for the Canada Thistle Study: Yij = Ili + bj + eij' i = SM, NM; j = 1, 2, ... , k. 
Under the assumption that eij is normally distributed, IlSM = 100, k = 10 (10 blocks), ex = 0.05, 
0 2 SM= 0 2 NM, ~L = -10 and ~u = 10, the performance of the decision rules corresponding to the 
traditional and equivalence analyses can be graphically illustrated. These assumptions are not 
neccessary for the relationship exhibited to hold, but are made to allow for the graphical 
representation that follows. 
First, consider the performance of the decision rule appropriate for the equivalence analysis, 
Ho: ~L ~ 1lm1- IlSM or 1lm1- IlSM ~ ~u vs HA : ~L < 1lm1- IlSM < ~u' where 
HA: ~L < 1lm1- IlSM < ~u indicates equivalence. This is illustrated in Figure 1 for 
combinations of the estimated difference between IlNM and IlSM and the estimated standard error 
of the difference between IlNM and IlSM' There are two properties to note. First, the conclusion 
of equivalence never occurs if the estimated difference in IlNM and IlSM is either greater than 10 
(~u) or less than -10 (~L)' Second, for a given estimated difference falling between 10 and -10, 
as the estimated standard error of the difference increases from 0, the decision rule indicates that 
the hypothesis testing result will change from a conclusion of equivalence to a conclusion of 
inequivalence. Both of these properties are appropriate, the first as a consequence of the 
objective of the trial being comparability, and the second as an illustration of the role variability 
plays in making decisions. 
Next, consider the performance of the decision rule appropriate for the traditional analysis, 
Ho: IlNM = IlSM vs HA : IlNM * IlSM' where Ho: IlNM = IlSM indicates equivalence. (Clearly, by the 
definition of equivalence, neither of the hypotheses from the traditional analysis are appropriate 
when the study objectives involve demonstrating IlNM and IlSM are comparable. But, if the 
traditional analysis is used, the null hypothesis is more indicative of equivalence than the 
alternative hypothesis.) Consider the two properties mentioned for the equivalence analysis, as 
illustrated in Figure 2 for combinations of the estimated difference of IlNM and IlsM and the 
estimated standard error of the difference between IlNM and IlSM' First, the conclusion of 
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equivalence can occur for any estimated difference in IlNM and IlSM! Obviously, this is not a 
desirable property for the hypothesis test as it in no way indicates that the eradication means are 
comparable. Second, for a given estimated difference, as the estimated standard error of the 
difference increases from 0, the decision rule indicates that the hypothesis testing result will 
eventually change from a conclusion of inequivalence to a conclusion of equivalence. This is the 
exact opposite of the equivalence analysis and is also not a desirable property. The performance 
of the traditional analysis should not be a suprise, as it is not addressing the objectives of the 
study. 
4 Current Equivalence Testing Methods 
Next, the framework needed to categorize and describe the current equivalence testing methods 
is presented. Appropriate modifications have been made to generalize the categories beyond the 
scope ofbioequivalence Hauck (1997) presented. 
To begin, specify a general linear mixed model similar to the model presented by Henderson 
(1984). Let y = Xp + ZU + E, where y is a vector of measured responses, X is a known matrix, p 
is a vector of unknown fixed effects, Z is a known matrix, U is a vector of random effects with 
E(U) = 0, E is a random vector with E( E) = 0 and V ar[ ~] = [~ :], where R and G are positive 
definite covariance matrices. Under these assumptions, E(y) = Xp and V(y) = ~ = ZGZ' + R, 
where the covariance parameters in ~ are denoted by 8. (Readers interested in a more detailed 
description are referred to Henderson.) Using this model for the Canada Thistle Study, results in 
[ 1 
D~ 
IlNM 2 P = and 8 = DSM . 
IlSM 2 
DNM 
Equivalence tests can be classified as either moment-based or probability-based. Moment-based 
equivalence tests test hypotheses which are a function of the parameters (moments) of the 
distribution ofy. Moment-based equivalence tests can be further classified into aggregate and 
disaggregate methods. 
An aggregate moment-based equivalence test involves a single hypothesis test which 
encompasses all parameters (from P and 8) of interest. The test of equivalence is dependent 
upon this hypothesis test, which can be expressed as 
Ho: ~L ~ fnc(~) or fnc(~) ~ ~u vs HA : ~L < fnc(~) < ~u· 
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An example of an aggregate moment-based test presented previously is 
Ho: LlL Z ~ or ~ Z Llu vs HA: LlL < ~M < Llu. A second example is 
~SM ~SM ~SM 
In this situation, 
A = E [( Y NMj - Y SMj ) ] 
2V *(YSM) 
where V *(y SMj) does not include block-to-block variability. For this hypothesis test, a lower 
bound is not necessary, but rather than create futher classifications, LlL can by definition be set to 
0, thus continuing with the use of an equivalence interval. 
A disaggregate moment-based equivalence test involves multiple hypothesis tests, where each 
hypothesis test involves subsets of the parameters (from P and 8) of interest. Thus, the 
equivalence testing process is dependent upon k hypothesis tests (k> 1), which can be expressed 
as HOI: LlLI Z fnc( ~) or fuc( ~) z LlUl vs HAl: LlL! < fuC( ~) < LlUl 
HOK: LlLK Z fuC(~) or fnc(~) z LlUK vs HAK: LlLK < fuC(~) < LlUK . 
Equivalence is concluded if all null hypotheses are rejected and partial equivalence can be 
concluded if at least one null hypothesis is rejected. 
An example of a disaggregate moment-based equivalence test is 
HOI: LlL! Z ~-~SM or ~ - ~SM Z LlUl VS HAl: LlL! < ~ - ~SM < LlUl' and 
Note that if the block effects (bj) and random errors (eij) for the randomized complete block 
design are normally distributed, a conclusion of equivalence for the disaggregate moment-based 
equivalence test example indicates a conclusion of equivalence in the distributions of the two 
eradication methods as the normal distribution is completely specifed by its mean and variance. 
Probability-based equivalence tests involve demonstrating with a sufficiently high probability 
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110 Kansas State University 
that measured responses for treatments are comparable. For example, consider Pj = P(thistle 
count for the Standard and New Methods satisfy a 'comparability criteria' at locationj), e.g. 
PrP(LlL < YNMj - YSMj < Llu)· We can then further classify probability-based equivalence tests as 
either tolerance interval or expectation methods. 
The expectation probability-based methods involve demonstrating E(Pj ) > 1'. If IIp = E(Pj ), then 
an appropriate hypothesis test is Ho: IIp $; l' versus HA : IIp> 1'. 
The tolerance interval probability-based methods involve demonstrating P(Pj > 1") > w. If 
P -r' = Pr(Pj > 1"), then an appropriate hypothesis test is Ho: P 1;' $; W versus HA : P 1;' > W. 
5 Examples 
Having given an overview of equivalence testing in the previous sections, it is appropriate to 
address the question of extending the concept of equivalence testing to various treatment and 
design structures. The literature does not address this question for designs other than the two-
period crossover design and the four-period, two-treatment replicate designs such as those 
described by Hauck(1997). An obvious place to begin this discussion is with the most basic 
design, a one-way treatment structure in a completely randomized design structure. The second 
example is a two-way treatment structure in a split-plot design with completely randomized 
design structure for the whole plot and sub plot experimental units. The philosophy and ideas 
illustrated in these two examples can be generalized to most common experimental designs used 
by agriculturists. 
One-Way Treatment Structure in a Completely Randomized Design Structure 
Consider the means model described in Milliken and Johnson (1992, Chapter 1): y = Xp + E, 
where E(y) = Xp, V(y) = ~ = 0 21, p' = [Ill 112 ... Ilt] and e = [02} Though there are typically 
several hypotheses related to the objectives of the study that are of interest, frequently the null 
hypothesis of equality of treatment or population means is the initial hypothesis tested when the 
objective of the study is to detect differences among the t treatment means (the traditional 
analysis). Here, assume the objective of the study is to assess the comparability of the t 
treatment means and to detect treatment equivalences, i.e., the situation where two or more 
treatment means are comparable. 
In trying to relate this objective to a hypothesis test, it is illustrative to consider the initial 
hypothesis test in the traditional analysis, the test of equality oftreatment means. Here, the null 
and alternative hypotheses can be expressed as Ho: Ill=1l2="'=llt vs HA : Ili *- Ili for some i *- j. 
The process of testing this hypothesis involves the use of a t-1 by t matrix of contrasts, such as 
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1 -1 0 0 0 0 0 0 
III -1l2 
1 1 -2 0 0 0 0 0 III +1l2 -21l3 
H= 1 1 1 -3 0 0 0 0 . Then HP = III + 112 + 113 - 3 114 and 
1 1 1 1 (t-1) 
III + .. ·Ilt -l - (t-l)llt 
the previous hypotheses can be expressed as Ho: HP = 0 vs HA: HP * 0 
The first step in an equivalence analysis is the correct specification of the null and alternative 
hypotheses. In the traditional analysis, the objective is to demonstrate there is a least one pair of 
population means that are different, thus the null hypothesis specifies that all population means 
are equal. For an equivalence analysis, the objective is to demonstrate that at least one pair of 
the population means is equivalent, thus the null hypothesis specifies that all pairs of population 
means are inequivalent. The correct formulation for the null and alternative hypotheses is then 
Ho: DoL ~ Ilcllj or Ilcllj ~ Dou for all i * j vs HA: DoL < Ilcllj < Dou for at least one i * j. 
For simplicity (and because it is reasonable in many equivalence testing situations), assume 
DoL = -Dou. Intuitively, it appears reasonable to reformulate the null and alternative hypotheses 
for the equivalence analysis using the contrast matrix H previously defined and vectors DoL and 
Dou, where the elements of DoL and Dou are appropriate upper and lower equivalence intervals for 
the linear contrasts represented by the elements ofHp. DoL and Dou are the lower and upper 
equivalence vectors, respectively. Then, the previous set of hypotheses can be expressed as 
Ho: DoL ~ HP or HP ~ Dou vs HA : DoL < HP < Dou, where HA : DoL < HP < Dou indicates that at least 
one of the elements ofHP is within the corresponding equivalence interval from DoL and Dou. 
The selection of the equivalence vectors should provide a mapping from 
Ho: DoL ~ Ilcllj or Ilcllj ~ Dou for all i * j to Ho: DoL ~ HP or HP ~ Dou. In particular, one might 
(t-l) 









and assess this mapping. (The 
elements of these vectors can be derived by considering the relationship among the population 
means for all combinations of inequivalence under the null hypothesis and relating those 
restrictions to the linear contrasts in Hp.) 
Unfortunately this mapping is not one-to-one except in the trivial situation where t=2. This 
occurs because the constraints represented by Ho: DoL ~ Ilcllj or Ilcllj ~ Dou for all i * j can not be 
replicated by the t-l degrees of freedom (t-l constraints) corresponding to the rank ofH. This 
result can be clearly illustrated using an example with a completely randomized design structure, 
a one-way treatment structure with t=3 populations, and Dou = 5. 
111 
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Using the matrix of contrasts defined previously, the two elements ofHP are III - 112 and 
III + 112 - 21l3' and the elements of d u are 10 and 15 (the elements of d L are -10 and -15). If 
III < 113 < 1l2' and each mean differs by at least 5 (du), then dL ~ Ilj-Ilj or Ilcllj ~ du for all i "* j. 
This situation illustrate why it is appropriate to consider ± 10 (2 * d u) for the equivalence interval 
on III - 112 from Hp. 
Next, consider III = 55, 1l2=65 and 1l3=60, here again dL ~ Ilcllj or Ilcllj ~ d u for all i "* j, but 
III + 112 - 2113 = 0 is <15 (3 * du) and > -15 (3 * dL). Hence Ho: dL ~ Ilcllj or Ilcllj ~ du for all 
i "* j incorrectly maps into HA: d L < HP < d u. Similarly, consider III = 30, 1l2=60 and 1l3=64, 
then d L < Ilj-Ilj < du for at least one i "* j (1l2-1l3=4), but III - 112 = 30 > 10 and III + 112 - 2113 = 38 
> 15, thus HP ~ d u, and HA: d L < Ilcllj < du for at least one i "* j incorrectly maps into 
Ho: d L ~ Hp or HP ~ d u' The problem is related to the order of the population means and the 
magnitude of their differences, e.g. when III < 113 < 112 a one-to-one mapping 
from Ho: dL ~ Ilj-Ilj or Ilcllj ~ du for all i "* j to Ho: d L ~ HP or HP ~ d u doesn't not exist for all 
possible combinations of Il/ s satisfying Ho: dL ~ Ilj-Ilj or Ilcllj ~ du for all i "* j. 
Thus the extension of the use of equivalence intervals for contrasts of the parameters (HP) is not, 
in general, acceptable for assessing Ho: dL ~ Ilj-Ilj or Ilcllj ~ du for all i "* j vs 
HA: dL < Ilcllj < du for at least one i "* j. However, under the assumption that d L = -du, the null 
and alternative hypothesis are equivalent to Ho: Illclljl ~ d u for all i "* j vs HA : I Ilcllj I < d u for at 
least one i "* j, which is equivalent to Ho: min(lllj-Iljl) ~ du vs HA: min(IIlClljl) < du, where 
min(lllClljl) is the smallest absolute difference among all possible unique pairs of the t treatment 
means. Hence, an assessment of the comparability of the t treatments can be conducted under 
the hypothesis test Ho: min(IIlClljl) ~ du for all i "* j vs HA: min(lllClljl) < du for all i "* j. 
Two-Way Treatment Structure in a Split-Plot Design Structure 
Next, consider a two-way treatment structure in a split-plot design using the means model as 
described in Milliken and Johnson (Chapter 5, Section 2). For this example, consider an 
extension of the Canada Thistle Study previously introduced. For this study, the 3 whole-plot 
treatments are the following eradication methods: 
Treatment 1: Application of a Common Herbicide in Conjunction with Tilling 
Treatment 2: Mowing in Conjunction with Tilling 
Treatment 3: Application of a Common Herbicide 
The 3 sub-plot treatments are: 
Treatment 1: Intermediate Wheatgrass 
Treatment 2: Western Wheatgrass 
Treatment 3: Control 
The intermediate and western wheatgrass treatments are the seeding of wheatgrass in addition to 
whatever treatment is applied to the whole-plot experimental unit, and the control treatment is 
equivalent to doing nothing in addition to whatever treatment is applied to the whole-plot 
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experimental unit. The response for the experiment is the thistle count two years after the 
attempted eradication. It was hypothesized that the wheatgrasses would provide additional 
supression of the thistles. The primary study objectives are to assess equivalence among 
eradication methods in combination with the two wheatgrass varieties and to assess if these 
treatment combinations are superior to the eradication method - control treatment combinations. 
An appropriate model is y = Xp + ZU + E, where P' = [1l11 1112 1113 1121 ••• 1l33] 
and 8' = [a~ a;pJ Here Ilij = average count for whole-plot treatment i and subplot treatment j, 
a~ is the variability among whole-plot experimental units, and a;p is the variability among 
sub-plot experimental units. Further description of X, Z, U and E is provided by Milliken and 
Johnson(1992). 
One approach to the analysis of the data from this study is to first determine if the wheatgrass 
variety - eradication method treatment combinations are superior to the eradication method -
control treatment combinations and to then determine ifthere is equivalence among eradication 
method - wheatgrass variety treatment combinations. Using this analysis approach, the first step 
in the analysis is to determine an appropriate hypothesis test for testing the superiority of the 
wheatgrass varieties versus control. To accomplish this step, Ho: min(llij' i=l ,2,3; j=l ,2) 
::s; max(Il13' 1l23' 1l33) vs HA: min(llij' i=1,2,3; j=1,2) > max(Il13' 1l23' 1l33) could be tested. This 
hypothesis test assesses if intermediate wheatgrass (Illl 1l2l' 1l3l) and western wheatgrass (1l12 
1l22' 1l32) provide superior thistle suppression to control' (1l13, 1l23' 1l33). This would be a ' 
reasonable hypothesis to test under the assumption that the population means for the eradication 
method - wheatgrass variety treatment combinations are equivalent. However, this may not be a 
reasonable assumption. 
If one is not willing to assume the population means for the eradication method - grass variety 
treatment combinations are equivalent or if the null hypothesis in the previous hypothesis test is 
not rejected, the next step in the analysis could be to test for the superiority of the wheatgrass 
varieties versus control for each whole-plot treatment, i.e. test HOi: min(llil' 1li2) ::s; lli3 vs 
Hai: min(llil, 1li2) > lli3 for i=1,2,3. 
Having addressed the objective of superiority of the wheatgrass varieties to control, it is 
appropriate to assess equivalence among the eradication and wheatgrass variety treatment 
combinations. As a starting point in determining what an appropriate first step might be, 
consider the traditional analysis approach. The first step in the the traditional analysis is a test 
for interaction. (For this experiment, this test would not involve the control- eradication 
treatment combinations as there is no interest in including them in the assessment of 
equivalence.) The interaction hypothesis from a traditional analysis can be expressed as 
Ho· II .. - 11.,. - II .. , + II.,., = 0 for all i*i' andJ· *J.' vs HA • II .. - II." - II .. , + II.,., * 0 for at least one ·I""'IJ I""'IJ I""'IJ I""'IJ • I""'IJ I""'IJ I""'IJ I""'IJ 
113 
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then HP = [ (!l11 - !l12) - (!l21 - !l22) ], and the previous hypotheses can be expressed as 
(!l11 -!l12 + !l21 - !ld - 2(!l31 - !l32) 
Ho: HP = 0 versus HA : HP * o. 
An analagous first step for an equivalence analysis is to test Ho: LlL < !lij - !li'j - !lij' + !li'j' < Llu 
for all i *i' and]' *]., vs HA ' LlL > II" - 11", - II .. , + 11"" or II .. - 11", - II .. , + 11"" > Llu for at least one • - I"'"'IJ I"'"'IJ I"'"'IJ I"'"'IJ I"'"'IJ I"'"'IJ I"'"'IJ I"'"'IJ-
i * i' and j * j '. These hypotheses arise naturally from the combination of the equivalence testing 
and interaction concepts, thus, the related hypothesis test is refferred to as a test for equivalence 
interaction. In the traditional analysis for interaction, no interaction is assumed 
(Ho: Ilij - Ili'j - Ilij' + !li'j' = 0 for all i *i' and j *j ') and a hypothesis test is conducted based on this 
assumption. In the equivalence analysis for equivalence interaction, no equivalence interaction 
(Ho: LlL < !lij - !li'j - !lij' + Ili'j' < Llu for all i * i' and j * j ') is assumed, and a hypothesis test based 
on this assumption is conducted. 
As with the previous example, when the rank ofH is greater than 1, it is not possible to construct 
a hypothesis test addressing equivalence interaction using the contrasts in HP that provides a 
one-to-one mapping with Ho: LlL < Ilij - Ili'j - Ilij' + Ili'j' < Llu' However, note that 
LlL < !lij - !li'j - !lij' + !li'j' < Llu for all i * i' and j * j' if and only if max(!lij - !li'j - !lij' + !li'j') < Llu 
and LlL < min(ll .. - II.,. - II .. , + II.,.,) where max(ll .. - II.,. - II .. , + II".,) is the maximum value of 
I"'"'IJ 1"'"'1 J I"'"'IJ 1"'"'1 J ' I"'"'IJ 1"'"'1 J I"'"'IJ 1"'"'1 J 
Ilij - Ili'j - !lij' + !li'j' when considering all appropriate i *i' and j *j' and min(llij - !li'j - !lij' + !li'j') is 
the minimum value of !lij - Ili'j - Ilij' + Ili'j' when considering all appropriate i *i' and j *j '. Here 
again, in most situations it is reasonable to assume LlL = -Llu, and under this assumption, 
max(ll .. - II,,. - II .. , + II.,.,) < Llu and LlL < min(ll .. - II.,. - II .. , + II.,.,) if and only if 
I"'"'IJ 1"'"'1 J I"'"'IJ 1"'"'1 J I"'"'IJ 1"'"'1 J I"'"'IJ 1"'"'1 J 
max(lllij - !li'j - Ilij' + lli'j,1) < Llu where max(l!lij - Ili'j - Ilij' + lli'j,1) is the maximum value of 
Illij - !li'j - !lij' + lli'j'l when considering all appropriate i * i' and j * j " thus the equivalence 
interaction hypotheses can be restated as Ho: max(l!lij - Ili'j - !lij' + lli'j,1) < Llu vs 
HA ' max(lll .. - II.,. - II .. , + 11"',1) > Llu where max(lll .. - II.,. - II .. , + 11·,·,1) is the maximum value of • I"'"'IJ I"'"'IJ I"'"'IJ I"'"'IJ - , I"'"'IJ I"'"'IJ I"'"'IJ I"'"'IJ 
Illij - Ili'j - !lij' + lli'j,1 when considering all appropriate i *i' and j *j '. 
In most experimental designs involving a two-way treatment structure, the researcher would like 
(if appropriate) to compare one set of treatments after averaging over the second set of 
treatments, e.g., for a split-plot design the researcher would like to compare the sub-plot 
treatments after averaging over the whole-plot treatments. IfHo: max(lllij - !li'j - !lij' + !li'j,1) < Llu 
is not rejected, it is appropriate to assess the equivalence of the whole-plot and sub-plot 
treatments (seperately) using the equivalence testing procedure presented for the one-way 
treatment structure in a completely randomized design structure. Hypothesis tests to assess the 
comparability of the whole-plot treatment means in order to detect whole-plot treatment 
equivalences, and to assess the comparability of the sub-plot treatment means in order to detect 
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sub-plot treatment equivalences can be conducted and interpretations can be made 
independently. IfHo: max(lllij - Ili'j - Ilij' + lli'j,1) < ~u is rejected, the equivalences among one 
set of treatments may depend on the level of the second set of treatments. Hypothesis tests to 
assess the comparability of whole-plot treatments and the comparability of sub-plot treatments 
can be conducted, but the interpretation of the results of these hypothesis tests may not be 
umelated (or even meaningful). 
6 Summary 
The use of equivalence testing, though not commonplace if occurring at all, is warranted in some 
experimental situations involving research in agriculture. There exists a wide variety of 
equivalence testing methods, but few (if any) have been generalized for use in designs other than 
the two-period crossover design and the four-period, two-treatment replicate designs commonly 
used in bioequivalence trials. This paper develops the philosophy and illustrates the application 
of that philosophy to two common experimental designs. These examples can be generalized to 
most common experimental designs used in agriculture experiments. However, there are several 
areas of research related to equivalence testing that need to be addressed before equivalence 
testing can successfully be used for the wide variety of designs employed in agricultural 
research. 
First, equivalence testing methodology based on distributional assumptions for y, or appropriate 
nonparametric methods must be developed. At the same time, methodology to address the 
overall or experimentwise error rate associated with the multiplicity of pairwise equivalence 
assessments (the equivalence analysis counterpart to pairwise comparisons in a traditional 
analysis) must be developed. 
Additionally, guidelines need to be developed to assist researchers in understanding and 
choosing appropriate ~L and ~u and appropriate equivalence testing methods as well as to 
delineate how to apply equivalence testing methods when interested in various inference spaces 
such as discussed by McLean et all (1991). 
After these initial research efforts, extensions of equivalence testing methods to all GLMMs, 
GLMs, group sequential tests and the field of covariance analysis will broaden the application of 
equivalence testing. 
The development of equivalence testing methods that are applicable to agricultural research and 
the simultaneous production of examples, guidelines and explanations to assist the researchers 
involved in this research will greatly benefit the efficiency and effectiveness of this research. 
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Equivalence and Inequivalence Regions for Equivalence and Traditional Analyses 
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